Gert L. Perlhagen - Net Worth and Insider Trading

Gert L. Perlhagen Net Worth

The estimated net worth of Gert L. Perlhagen is at least $110 Million dollars as of 2024-09-18. Gert L. Perlhagen is the Director of NovoCure Ltd and owns about 6,125,000 shares of NovoCure Ltd (NVCR) stock worth over $110 Million. Details can be seen in Gert L. Perlhagen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gert L. Perlhagen has not made any transactions after 2017-03-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gert L. Perlhagen

To

Gert L. Perlhagen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gert L. Perlhagen owns 1 companies in total, including NovoCure Ltd (NVCR) .

Click here to see the complete history of Gert L. Perlhagen’s form 4 insider trades.

Insider Ownership Summary of Gert L. Perlhagen

Ticker Comapny Transaction Date Type of Owner
NVCR NovoCure Ltd 2017-03-14 director

Gert L. Perlhagen Latest Holdings Summary

Gert L. Perlhagen currently owns a total of 1 stock. Gert L. Perlhagen owns 6,125,000 shares of NovoCure Ltd (NVCR) as of March 14, 2017, with a value of $110 Million.

Latest Holdings of Gert L. Perlhagen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NVCR NovoCure Ltd 2017-03-14 6,125,000 17.92 109,760,000

Holding Weightings of Gert L. Perlhagen


Gert L. Perlhagen Form 4 Trading Tracker

According to the SEC Form 4 filings, Gert L. Perlhagen has made a total of 0 transactions in NovoCure Ltd (NVCR) over the past 5 years. The most-recent trade in NovoCure Ltd is the acquisition of 125,000 shares on March 14, 2017, which cost Gert L. Perlhagen around $866,250.

Insider Trading History of Gert L. Perlhagen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gert L. Perlhagen Trading Performance

GuruFocus tracks the stock performance after each of Gert L. Perlhagen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gert L. Perlhagen is 113.57%. GuruFocus also compares Gert L. Perlhagen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gert L. Perlhagen within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gert L. Perlhagen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gert L. Perlhagen

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 49.29 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 50.83 LIMIT LIMIT LIMIT LIMIT LIMIT

Gert L. Perlhagen Ownership Network

Ownership Network List of Gert L. Perlhagen

No Data

Ownership Network Relation of Gert L. Perlhagen

Insider Network Chart

Gert L. Perlhagen Owned Company Details

What does NovoCure Ltd do?

Who are the key executives at NovoCure Ltd?

Gert L. Perlhagen is the director of NovoCure Ltd. Other key executives at NovoCure Ltd include Chief Financial Officer Ashley Cordova , Chief Financial Officer Wilhelmus Cm Groenhuysen , and President & CNS Cancers US Frank X Leonard .

NovoCure Ltd (NVCR) Insider Trades Summary

Over the past 18 months, Gert L. Perlhagen made no insider transaction in NovoCure Ltd (NVCR). Other recent insider transactions involving NovoCure Ltd (NVCR) include a net sale of 5,921 shares made by Wilhelmus Cm Groenhuysen , a net sale of 2,715 shares made by Ashley Cordova , and a net sale of 4,597 shares made by Frank X Leonard .

In summary, during the past 3 months, insiders sold 688 shares of NovoCure Ltd (NVCR) in total and bought 0 shares, with a net sale of 688 shares. During the past 18 months, 16,780 shares of NovoCure Ltd (NVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 16,780 shares.

NovoCure Ltd (NVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NovoCure Ltd Insider Transactions

No Available Data

Gert L. Perlhagen Mailing Address

Above is the net worth, insider trading, and ownership report for Gert L. Perlhagen. You might contact Gert L. Perlhagen via mailing address: 39 Thurloe Square, London X0 Sw7 2sr.

Discussions on Gert L. Perlhagen

No discussions yet.